Exploring the Ability of Meningococcal Vaccines to Elicit Mucosal Immunity: Insights from Humans and Mice [PDF]
Neisseria meningitidis causes a devastating invasive disease but is also a normal colonizer of the human nasopharynx. Due to the rapid progression of disease, the best tool to protect individuals against meningococcal infections is immunization. Clinical
Elissa G. Currie, Scott D. Gray-Owen
doaj +4 more sources
Systematic literature review on the safety and immunogenicity of rotavirus vaccines when co-administered with meningococcal vaccines [PDF]
This study is aimed to review the published evidence on safety, immunogenicity, and efficacy of rotavirus vaccines when co-administered with meningococcal vaccines in infants. A systematic literature search was performed in four databases containing peer-
Priya Pereira +2 more
doaj +2 more sources
Meningococcal glycoconjugate vaccines [PDF]
Neisseria meningitidis is a major cause of invasive bacterial infections worldwide. For this reason, efforts to control the disease have been directed at optimizing meningococcal vaccines and implementing appropriate vaccination policies. In the past, plain polysaccharide vaccines containing purified capsular polysaccharides A, C, Y and W135 were ...
GASPARINI, ROBERTO, PANATTO, DONATELLA
openaire +3 more sources
Concomitant administration of meningococcal vaccines with other vaccines in adolescents and adults: a review of available evidence [PDF]
Invasive meningococcal disease (IMD), a rapidly progressing and potentially fatal illness, disproportionately affects adolescents and young adults. While IMD is best prevented by vaccination, vaccine uptake in these groups is low.
Justine Alderfer +6 more
doaj +2 more sources
Suboptimal uptake of meningococcal vaccines among older adolescents: Barriers, solutions, and future research directions [PDF]
Over the past 15 y, several vaccines have been added to the recommended immunization schedule for adolescents in the United States. In addition to annual influenza vaccination, the Advisory Committee on Immunization Practices recommends tetanus ...
Linda M. Niccolai, Caitlin E. Hansen
doaj +2 more sources
Meningococcal Vaccines: Current Status and Emerging Strategies [PDF]
Neisseria meningitidis causes most cases of bacterial meningitis. Meningococcal meningitis is a public health burden to both developed and developing countries throughout the world.
Pumtiwitt C. McCarthy +2 more
doaj +2 more sources
Meningococcal conjugate vaccines: optimizing global impact
Andrew Terranella1,2, Amanda Cohn2, Thomas Clark2 1Epidemic Intelligence Service, Division of Applied Sciences, Scientific Education and Professional Development Program Office, 2Meningitis and Vaccine Preventable Diseases Branch, National Center for ...
Terranella A, Cohn A, Clark T
doaj +1 more source
Short‐Term Safety of Concomitant Meningococcal B and National Immunisation Program Vaccines in Infants Aged < 15 Months: A Survey‐Based Surveillance Study [PDF]
ABSTRACT Objective To examine short‐term safety outcomes following vaccination at 2‐, 4‐, 6‐ and 12‐month timepoints, comparing infants receiving meningococcal B (MenB) vaccines concomitantly with National Immunisation Program (NIP) vaccines to those receiving vaccines at separate visits. Study Type Observational cohort survey study.
Thuy Nguyen +9 more
wiley +2 more sources
Meningococcal vaccine information on YouTube in Türkiye: A cross-sectional analysis of content quality and reliability [PDF]
Meningococcal infections represent a significant public health concern due to their high mortality and morbidity rates. In Turkey, meningococcal vaccines are not included in the routine immunization schedule, and families increasingly seek health-related
Ayse Esra Tapci +2 more
doaj +2 more sources

